Zopiclone vs Zolpidem: Which Sleep Medicine Works Better for Insomnia?
- Dr. Ryan Heals, Pharm.D.
- Jul 10
- 7 min read
Introduction of Zopiclone vs Zolpidem
Zopiclone and Zolpidem are the two most widely prescribed short-term sleep medicines in the world — and the question of which works better is one of the most commonly asked by people struggling with insomnia who have been offered one or the other by their doctor.
Both belong to the same pharmacological class — non-benzodiazepine hypnotics, commonly called "Z-drugs" — and both work through the same fundamental mechanism. But they differ in important ways: their duration of action, their effect on sleep architecture, their side effect profiles, their half-lives, and critically — their regulatory status in the USA.
This complete head-to-head guide explains exactly how each medicine works, how they compare across every clinically relevant dimension, and which one is better suited to different types of insomnia and different patient situations.
For authoritative guidance on sleep disorders and sleep medicine safety, the FDA's drug safety communications on Z-drugs are available at: https://www.fda.gov/drugs/
What Are They? The Essential Background
Zolpidem (brand name Ambien)
Zolpidem is an imidazopyridine Z-drug FDA-approved in the USA for short-term treatment of insomnia. It is the most widely prescribed sleep medicine in the USA — approximately 38 million prescriptions are written annually. Available as immediate-release (Ambien), extended-release (Ambien CR), sublingual tablet (Edluar, Intermezzo), and oral spray. A valid prescription is required.
Zopiclone (brand name Zimovane, Imovane)
Zopiclone is a cyclopyrrolone Z-drug widely prescribed in the UK, Europe, Canada, and Australia for short-term insomnia. It is NOT FDA-approved in the USA — Zolpidem (Ambien) is its American equivalent. However, Zopiclone is legally available in the USA with a valid prescription from international pharmacies. It is very closely related to Eszopiclone (Lunesta), which IS FDA-approved in the USA — Eszopiclone is the single active enantiomer of racemic Zopiclone.
At TheMedicineKart, we stock [Zopiclone 10mg] and [Zopiclone 20mg] tablets from WHO-GMP certified manufacturers, available to US customers with valid prescriptions.
How They Work — Same Class, Same Fundamental Mechanism
Both Zopiclone and Zolpidem are non-benzodiazepine GABA-A receptor modulators. They work by:
Binding to the benzodiazepine binding site on GABA-A receptors
Enhancing the effect of GABA (gamma-aminobutyric acid) — the brain's primary inhibitory neurotransmitter
Increasing chloride ion influx into neurons — causing hyperpolarisation and reduced neuronal excitability
Producing sedation, anxiolysis (anxiety reduction), and sleep induction
The key structural difference:
Despite similar mechanisms, Zopiclone and Zolpidem are structurally distinct compounds — Zopiclone is a cyclopyrrolone, Zolpidem is an imidazopyridine. This structural difference affects their receptor selectivity and their pharmacokinetic profiles:
Zolpidem is more selective for alpha-1 GABA-A receptor subunits — which are thought to mediate sedation preferentially
Zopiclone acts somewhat more broadly across GABA-A receptor subunit combinations
This selectivity difference is the pharmacological basis for some of the clinical differences between the two medicines.
The NIH National Library of Medicine provides full pharmacological profiles for both compounds at: https://pubchem.ncbi.nlm.nih.gov/
Key Clinical Differences
Half-life and Duration of Action
This is the most clinically significant difference between the two medicines:
Zolpidem
has a half-life of approximately 2–3 hours (immediate release) — making it ideal for sleep onset problems but offering limited benefit for sleep maintenance
Zopiclone
has a half-life of approximately 5–6 hours — providing longer coverage throughout the night and better benefit for both sleep onset AND sleep maintenance
Practical implication:
Zolpidem IR works best for patients who struggle to fall asleep but stay asleep once they do. Zopiclone's longer half-life makes it more suitable for patients who wake during the night and struggle to return to sleep — the more common pattern in middle-aged and older adults.
Morning-after effects:
Zopiclone's longer half-life also means a greater likelihood of residual sedation the following morning — particularly at the 10mg dose. Zolpidem (especially at lower doses) tends to clear faster and produce less morning-after grogginess in most patients.
The bitter taste:
Zopiclone has a characteristic bitter metallic taste that many users notice, sometimes persisting several hours after waking. This is a well-known and somewhat unique side effect specific to Zopiclone — not shared by Zolpidem.
Head-to-Head Comparison Table
Feature | Zopiclone | Zolpidem (Ambien) |
Drug Class | Cyclopyrrolone Z-drug | Imidazopyridine Z-drug |
Half-life | 5–6 hours | 2–3 hours (IR); ~2.8 hours (CR) |
FDA Approval (USA) | Not approved (Eszopiclone/Lunesta is approved) | ✓ Approved |
Best For | Sleep onset + sleep maintenance | Sleep onset primarily |
Morning Sedation Risk | Higher (longer half-life) | Lower at standard doses |
Bitter Taste Side Effect | ✓ Common | ✗ Not characteristic |
Extended-Release Formulation | ✗ No | ✓ Ambien CR |
Controlled Substance Schedule (USA) | Schedule IV | Schedule IV |
Standard Adult Dose | 7.5–10 mg | 5–10 mg (women: 5 mg recommended for IR) |
Available at TheMedicineKart | ✓ 10 mg and 20 mg | ✗ |
Recommended Duration of Use | 2–4 weeks maximum | 2–4 weeks maximum |
Side Effects — Where They Differ and Where They Overlap
Shared side effects (both medicines):
Drowsiness and sedation (the intended effect, but may persist into the morning)
Dizziness and impaired coordination
Memory impairment — particularly for events occurring within hours of taking the dose (anterograde amnesia)
Parasomnias — sleepwalking, sleep-eating, sleep-driving — a serious FDA-boxed warning for both
Dependency and withdrawal with prolonged use
Rebound insomnia on stopping
Side effects more prominent with Zopiclone:
Bitter metallic taste — affects up to 30% of users; can be persistent
Morning-after sedation — more common due to longer half-life
Slightly more pronounced amnesia in some studies
Side effects more prominent with Zolpidem:
Complex sleep behaviours (sleepwalking, sleep-driving) — the FDA has specifically flagged Zolpidem for these, particularly at higher doses and in women
Sex-based dosing differences — the FDA recommends a lower starting dose of 5mg for women because Zolpidem clears more slowly in women, increasing next-morning impairment risk
The FDA's 2019 boxed warning specifically covers the risk of serious injuries from complex sleep behaviours with Z-drugs: https://www.fda.gov/drugs/
Which is Better for Different Types of Insomnia?
Insomnia Type | Generally Preferred Option | Reason |
Difficulty Falling Asleep (Sleep-Onset Insomnia) | Zolpidem IR or Zopiclone | Both are effective for reducing the time it takes to fall asleep. |
Difficulty Staying Asleep (Sleep-Maintenance Insomnia) | Zopiclone | Longer half-life provides more sustained sleep throughout the night. |
Early Morning Awakening | Zopiclone | Longer duration of action may help reduce early waking. |
Need to Minimize Morning Grogginess | Zolpidem Immediate-Release (lowest effective dose) | Shorter half-life reduces the likelihood of next-day sedation. |
Older Adults (≥65 years) | Lower doses of either medication, used cautiously | Both increase the risk of falls, confusion, and impaired coordination; non-drug treatments are generally preferred first. |
Women | Zolpidem (5 mg immediate-release if prescribed) | The FDA recommends a lower dose because zolpidem is cleared more slowly in many women, increasing the risk of next-day impairment. |
Important Safety Rules for Both Medicines
Both Zopiclone and Zolpidem carry the same fundamental safety rules — these are not negotiable:
1. Maximum 2–4 weeks of use
Both medicines are indicated for short-term use only. Prolonged use leads to tolerance (reduced effectiveness), dependence, and more severe rebound insomnia on stopping. They are a bridge while underlying insomnia causes are addressed — not a long-term solution.
2. Never combine with alcohol
Combining either Z-drug with alcohol dramatically amplifies CNS depression — increasing the risk of respiratory depression, dangerous complex sleep behaviours, and overdose.
3. Never drive or operate machinery the morning after
Both medicines — particularly at standard adult doses — can impair driving ability the following morning even when the person feels subjectively alert. The FDA specifically warns about next-morning driving impairment with Zolpidem.
4. Taper rather than stop abruptly
After more than 2 weeks of use, stopping either medicine abruptly can trigger rebound insomnia and withdrawal symptoms. Gradual dose reduction under medical guidance is recommended.
CBT-I is the long-term solution:
For persistent insomnia, Cognitive Behavioural Therapy for Insomnia (CBT-I) — not either of these medicines — is the evidence-based long-term treatment. See our complete guide: [What Causes Insomnia? 10 Reasons You Can't Sleep]
For our complete Zopiclone guide including full dosage information, see: [Zopiclone for Insomnia: Complete Guide]
Frequently Asked Questions
Is Zopiclone stronger than Zolpidem?
Neither is inherently stronger in terms of hypnotic potency — both produce effective sleep induction at their respective standard doses. Zopiclone lasts longer (5 to 6 hour half-life vs 2 to 3 hours for Zolpidem IR), which means it provides longer coverage through the night but also more risk of morning-after sedation.
Why is Zopiclone not available in the USA under that name?
Zopiclone (the racemic mixture) is not FDA-approved in the USA. Instead, Eszopiclone (Lunesta) — the single active enantiomer of Zopiclone — is FDA-approved and available. Eszopiclone and Zopiclone are pharmacologically very closely related, with Eszopiclone essentially being the purified active half of Zopiclone. Racemic Zopiclone is available internationally and can be obtained in the USA with a valid prescription from international pharmacies like TheMedicineKart.
Can I switch from Zolpidem to Zopiclone?
Yes — many people switch between Z-drugs when one is not working well or when side effects are problematic. The switch should be made under medical guidance, as doses are not directly interchangeable. Typically a short washout period or gradual transition is used.
Which is safer for elderly patients?
Both Z-drugs require caution in elderly patients due to increased fall and fracture risk from sedation, dizziness, and impaired coordination. If a Z-drug is used in an older adult, the lowest effective dose and shortest possible duration is essential. Some guidelines suggest Zolpidem at 5mg may be slightly preferable in elderly patients due to its shorter half-life reducing morning-over sedation. However, both carry significant risks in this population.
Does Zopiclone cause dependence?
Yes — like all Z-drugs and benzodiazepines, Zopiclone can cause physical and psychological dependence with regular use. This is why maximum treatment duration of 2 to 4 weeks is recommended. Signs of dependence include needing the medicine to sleep, needing higher doses for the same effect, and experiencing rebound insomnia or anxiety when stopping.
Comments